## Abstract ## BACKGROUND. Chronic hepatitis C can result in fatty changes in the liver. Previous studies have suggested that hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus (HCV) infection. The authors sought to determine whether hepatic steatosi
De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis
โ Scribed by Saxena, Romil ;Ye, Ming Q. ;Emre, Sukru ;Klion, Franklin ;Nalesnik, Michael A. ;Thung, Swan N.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1999
- Tongue
- English
- Weight
- 25 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1074-3022
No coin nor oath required. For personal study only.
โฆ Synopsis
We report a case of de novo hepatocellular carcinoma (HCC) in a patient with recurrent hepatitis C (HCV) and cirrhosis 7 years after orthotopic liver transplantation (OLT). This is a previously unreported observation in the natural history of post-transplantantion HCV infection and reiterates the strong oncogenic potential of HCV.
๐ SIMILAR VOLUMES
## Background: The optimal treatment for hepatocellular carcinoma (hcc) is surgical resection. however, only a small percentage of patients are operative candidates. percutaneous radiofrequency interstitial thermal ablation proved to be effective, too. our objective was to assess a novel operative
approximately 3%. 3,4 Early detection of HCC in cirrhotic pa-A prospective study was performed to establish tients can usually be achieved by screening with noninvasive whether infection with specific hepatitis C virus (HCV) techniques, such as ultrasound (US) scan and serum a-fetogenotypes was ass